Minodronic Acid

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
012320142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
2017
Minodronic acid is an aminobisphosphonate that is an antagonist of purinergic P2X2/3 receptors involved in pain. The aim of this… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2016
2016
The effect of treatment for 9months with minodronic acid, a nitrogen-containing bisphosphonate, on vertebral mechanical strength… (More)
Is this relevant?
2016
2016
BACKGROUND Estrogen deprivation therapy for myoma/adenomyosis decreases bone mineral density and can only be applied in the short… (More)
  • table 1
  • figure 1
Is this relevant?
2015
2015
Minodronic acid (MA) is a third-generation bisphosphonate (BP). Its high potency allows lower doses to be administered in… (More)
Is this relevant?
2015
2015
PURPOSE Minodronic acid is a third-generation bisphosphonate being developed for the treatment of osteoporosis. The aim of this… (More)
  • figure 1
  • table I
  • figure 2
  • table III
  • figure 3
Is this relevant?
2015
2015
Quantitative analysis of the orientational distribution of biological apatite (BAp) crystals is proposed as a new index of bone… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2015
2015
The purpose of this study was to evaluate the effects of withdrawal of minodronic acid (MIN) for 3 months after 12 months of… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
The purpose of the present study was to determine whether teriparatide and monthly minodronic acid would have an additive effect… (More)
Is this relevant?
2014
2014
The goal of the study was to compare the effects of minodronic acid on bone mineral density (BMD) and bone turnover in a rat… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?